Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.08 USD | +0.25% | -2.97% | +54.15% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.15% | 230M | |
+45.86% | 56.65B | |
-6.38% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.57% | 26.75B | |
-21.39% | 19.03B | |
+0.04% | 12.28B | |
+24.07% | 12.26B | |
+28.35% | 12.04B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- RBC Cuts Price Target on Design Therapeutics to $4 From $7 Amid Limited Near-Term Clinical Updates, Keeps Sector Perform, Speculative Risk